Posterior Capsule Opacification (PCO) Evaluation of the AcrySof SN60AT Lens vs. SN60WF Lens

Alcon

Status: Completed

Conditions: Cataract

Treatments: Device: SN60WF; Device: SN60AT

Study type: Interventional

Funder types: Industry

Identifiers

NCT00762021

P-06-26

Details and patient eligibility

About

To assess posterior capsule opacification (PCO) in patients implanted with either the AcrySof SN60AT lens or the AcrySof SN60WF lens.

Enrollment: 104 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with bilateral senile cataracts
• Age > 50 years
• Fit for hospital follow ups
• Pupils dilating > 6mm preoperatively
• Eyes expected to see 6/12 or better postoperatively

Exclusion criteria

• Diabetes
• On treatment for glaucoma
• Other ocular pathology
• Previous ocular surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

104 participants in 2 patient groups

SN60AT

Experimental group

Description:

Implantation with the AcrySof Intraocular Lens Model SN60AT

Treatment:

Device: SN60AT

SN60WF

Active Comparator group

Description:

Implantation with the AcrySof Intraocular Lens Model SN60WF

Treatment:

Device: SN60WF